2015, Number 6
<< Back
Rev Mex Neuroci 2015; 16 (6)
Cavernous sinus syndrome due breast cancer metastases: Case report and literature review
Medina-Barrionuevo R, Jorge-Barroso HL, Apodaca-Cruz A, Gijón-Mitre V
Language: Spanish
References: 18
Page: 71-78
PDF size: 400.72 Kb.
ABSTRACT
Introduction: Cavernous sinus syndrome usually occurs
as unilateral ophthalmoplegia and ipsilateral facial pain with
involvement of cranial nerves in the parasellar region due to
infectious, inflammatory, vascular or primary neoplasms causes.
Infrequently, it is also described as an etiology the metastasis of solid
tumors involving the cavernous sinus.
Case Report: We describe the case of a 46-year-old female
diagnosed with breast cancer with clinical Stage IIIA, with 3 weeks
frontal headache, left orbital pain and intermittent diplopia.
Neurological examination revealed palpebral ptosis, dilated pupil
with absence of pupillary reflexes and complete ophthalmoplegia of
the left eye, hypoesthesia in frontal region and ipsilateral jaw. The
MRI revealed the presence of tumor lesion in the left cavernous sinus.
Conclusion: Cavernous sinus syndrome can be a presentation
of distant metastases of solid tumors. The particular clinic with
ophthalmoparesis and painful headache as in the case presented
should prompt this rare manifestation of breast cancer.
REFERENCES
Pestalozzi BC, Zahrieh D, Price KN, et al. Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol 2006; 17: 935-44.
Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R. Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer 2006; 107: 696-704.
Hines SL, Vallow LA, Tan WW, McNeil RB, Perez EA, Jain A. Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer. Ann Oncol 2008; 19: 1561-5.
Gabos Z, Sinha R, Hanson J, et al. Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer. J Clin Oncol 2006: 24: 5658-63.
Lin NU, Bellon JR, Winer EP. CNS metastases in breast cancer. J Clin Oncol 2004; 22: 3608-17.
Young Ann y cols. Cavernous sinus metastasis of non small cell lung cancer. Tuberc Respir Dis 2010; 69: 381-384
Birgull Obec y cols. Cavernous sinus syndrome caused by metastatic colon carcinoma. Clinical colorectal cáncer .Vol.6, N°8:593-596
Greenberg. Manual de Neurocirugía 6ta edició.New York: Thieme Publishing Group, 2006; 294-296
Laorporn Pawakranond y cols. MRI Findings of the cavernous sinus metastasis with inferior extension mimicking a nasopharyngeal carcinoma with cavernous sinus invasion.J Med Assoc Thai .Vol.89; N°6 :890-895
Nuriye Yildrim y cols. Case report: cavernous sinus metastasis of the parotid carcinoma: a very unusual case. Journal of Neuro-Oncology. 73 : 181-183
Robert J. Weil, Diane C. Palmieri, Julie L. Bronder et al. Breast cancer metastasis to the central nervous system. Am J Pathol 2005, 167: 913-920.
A. Evans y cols. Brain metastasis from breast cancer: identification of a high – risk group. Clinical Oncology 16: 345-349.
Frympas G, Televantou D, Papageorgiou V, et al. Unsuspected breast carcinoma presenting as orbital complication of
rhinosinusitis. Eur Arch Otorhinolaryngol. 2008; 265(8):979-82.
Ryan MW, Rassekh CH, Chaljub G. Metastatic breast carcinoma presenting as cavernous sinus syndrome. Ann otol Rhinol Laryngol; 1996: 105 (8): 666-668
Martin Polo J, Rivas López T, Martin Polo R, et al. Cavernous sinus syndrome: an initial expression of a breast carcinoma. Neurologia 2005, 20(3):153-155.
Khaw KW, Ramli N, Rahmat K. Ptosis due to cavernous sinus syndrome as a rare presentation of advanced breastmetastasis in a patient with delayed diagnosis. Malaysian Family Physician. 2012; 7(1):31-33
Cheng YC y cols.Improvent of suvervival and prospect of cure in patients with metastatic breast cancer. Breast cancer 2012;3: 191-199